Even with raising awareness about the risks of antibiotic misuse, how many of you still believe or know that the fastest way to reduce a disease is, whether it is the fastest way to reduce a disease Be a common cold, flu or infection, to take antibiotics? How many times you hear, “Don’t delay in taking antibiotics; it will delay recovery,” or knows someone who stopped an antibiotic course because they started feeling better? Addressing the dangerous consequences of antimicrobial resistance (AMR), a senior scientist of ICMR, Dr. Kamini Walia and a dedicated expert in the region, last night shared ET Business Conclave and Awards 2025, especially with us in 2025.

To help the audience understand, Dr. Kamini broke AMR into the simplest words and opened the discussion. “Some 10 or 20 years ago, we used a separate set of antibiotics. You can miss taking septran for sore throat, but now that drug has disappeared because insects that cause sore throat have become resistant to it. Many people take Norfloxacin for loose stool, but now it has also become ineffective in treating diarrhea infection. This is why we should use antimicrobial, whether antifungal or antibacterial drugs, with caution. Anti -antimicrobial resistance is emerging due to antimicrobial abuse. During Kovid, we had no specific treatment, yet people were taking ezithromycin, monocafe and many other misuse drugs. “Imagine a time when our body no longer does not respond to antimicrobial, leave us with an option without any treatment!

She further says, “AMR is called a silent epidemic, because when someone gets TB, Polio, or even Kovid, the system is informed. But how many drug-resistant infections are reported. Is given by people who have been dying of drugs due to almost no one, despite working in AMR space due to infections due to infections. Is. “

Do we have enough antimicrobial in India?

Large investment, time and billions of dollars have been inserted in the discovery of new drugs. Dr. Kamini shared how in the last few years, India has introduced some antibiotics, not only for the Indian market, but also for global use, with some ongoing global tests. “Recently, the Department of Biotechnology, in collaboration with an Indian pharmaceutical company, launched a new drug for nephithromycin, lung infection. Therefore, while the antibiotic discovery is still happening, the golden age, when the discoveries are often behind us, and less new drugs.

Another challenge is delay in creating antibiotics discovered in the West available for Indian patients. In addition, many of these drugs are ineffective against specific resistance patterns seen in India, which are limited to their use. These factors contribute to increasing intervals to effective treatment options. ,

Are we ready to compete with the disease X?

Dr. Kamini says that Kovid was a global emergency, but India handled it well. “The clinical capacity of the country improved significantly. Initially, communication was a challenge because very rarely about the virus or treatment was known, but it improved over time. Eventually, there was a broad message on prevention. I personally know many people who never got covids, and it will be a strategy to move forward. The government is investing in making the diagnosis more accessible. At the same time, more and more community vigilance is required. Social media often creates unnecessary publicity, and we should rely only the facts. This is where effective communication plays an important role. Rapid digitization allowed real -time data availability, helping the government take more informed decisions. In addition, the Covid program was directly monitored by the PMO and the Home Minister, in which funds were made available. To combat the future epidemic, we will again need a high level of focus and we have learned that from Kovid.

Now get the latest news with health and braking news and top headlines worldwide.